Cargando…

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure

Detalles Bibliográficos
Autores principales:	Pettit, Natasha, Delacruz, Jennifer, Han, Zhe, Landon, Emily, Pisano, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781649/ http://dx.doi.org/10.1093/ofid/ofu052.340

Ejemplares similares

203 Optimization of Posaconazole (PCZ) Dosing with Multi-disciplinary Therapeutic Monitoring (TDM) Protocol
por: Pettit, Natasha, et al.
Publicado: (2014)

731 Utility of Ceftaroline in the Treatment of Persistent Bacteremia and Deep-Seated Infections
por: Burgess, Donna R., et al.
Publicado: (2014)

204 Voriconazole Restriction in Addition to Therapeutic Drug Monitoring (TDM) Protocol Results in Optimized Dosing
por: Pettit, Natasha, et al.
Publicado: (2014)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

214 Social Media as a Tool for Antimicrobial Stewardship
por: Pisano, Jennifer, et al.
Publicado: (2014)

678 Ceftaroline vs Vancomycin in Treatment for Skin and Soft Tissue Infections (SSTI) in Obese Patients
por: Nguyen, Hao, et al.
Publicado: (2014)

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia
por: Kamath, Meghan, et al.
Publicado: (2021)

729 Activity of Ceftaroline and Comparator Agents Tested against Staphylococcus aureus from Patients with Bacteremia in United States (USA) Medical Centers (2009-2013)
por: Sader, Helio S., et al.
Publicado: (2014)

472 Ceftaroline-induced Neutropenia: Two Case Reports
por: Martin, Kelly E., et al.
Publicado: (2014)

192 Vancomycin Dosing in Obese and Morbidly Obese Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia
por: Morrill, Haley, et al.
Publicado: (2014)

809 Contemporary Experience with Ceftaroline Fosamil for the Treatment of Community-acquired Bacterial Pneumonia
por: Johnson, Leonard B, et al.
Publicado: (2014)

721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
por: Khatib, Riad, et al.
Publicado: (2014)

395 Impact of vancomycin pharmacokinetic/pharmacodynamic data on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children
por: Yoo, Reenar, et al.
Publicado: (2014)

473 Comparison of MicroScan System Prompt and Turbidity Methods for Measuring Vancomycin Minimum inhibitory concentration (MIC) against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 2ug/ml, the Clinical Implications and economic impact of using alternative antimicrobial agents to vancomycin for MRSA with possible MIC of 2ug/ml
por: Kamran, Amir, et al.
Publicado: (2014)

469 The Relationship between Vancomycin Minimum Inhibitory Concentrations (MICs) and Treatment Failure among Patients with Methicillin-Resistant Staphylococcus aureus Blood Stream Infections (MRSA-BSI) at the University of Connecticut Health Center (UCHC)
por: Gemtessa, Tilahun Amdissa, et al.
Publicado: (2014)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

724 Vancomycin Minimum Inhibitory Concentration Does Not Predict Death, Recurrence or Readmission in Patients with Staphylococcus aureus Bacteremia in a Safety-Net Hospital
por: Baxi, Sanjiv, et al.
Publicado: (2014)

679 Ceftaroline Fosamil (CPT-F) for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in Obese Patients
por: Kaye, Keith, et al.
Publicado: (2014)

728 Evaluation of Empirical Regimens Including Antistaphylococal Beta-lactam Antibiotics vs Vancomycin Monotherapy on Outcomes of Patients with Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia
por: Terico, Adrienne, et al.
Publicado: (2014)

811 Antimicrobial activity of ceftaroline tested against respiratory tract infection (RTI) pathogens isolated from USA medical centers in 2013
por: Sader, Helio S., et al.
Publicado: (2014)

288 Lack of Synergy With Six Blood Isolates of Methicillin-Resistant Staphylococcus aureus (Vancomycin MIC of 2) Tested With Combinations of Vancomycin + Gentamicin, Vancomycin + Rifampin and Vancomycin + Cefazolin.
por: Long, Virginia, et al.
Publicado: (2014)

280 Association between acessory gene regulator II expression and mortality among critically ill patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus bacteremia
por: Rosa, Regis, et al.
Publicado: (2014)

764 Risk Factors for Failure of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Management of Staphylococcus aureus Bacteremia (SAB)
por: Veillette, John, et al.
Publicado: (2014)

276 Molecular Epidemiology of MRSA and VRE Co-colonization among Hospitalized Adults in Detroit
por: Martin, Emily T., et al.
Publicado: (2014)

272 Characteristics of USA500/Iberian Methicillin-Resistant Staphylococcus aureus (MRSA) Invasive Disease
por: Melendez, Andre G., et al.
Publicado: (2014)

393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014)

1652 Retrospective Comparision of Oral Vancomycin Capsules vs Oral Vancomycin Solution for the Treatment of Severe Clostridium Defficile Infection
por: Saleh, Rania, et al.
Publicado: (2014)

396 What is the Best Predictor for Vancomycin Nephrotoxicity?
por: Hammoud, Kassem, et al.
Publicado: (2014)

672 Staphylococcus aureus Bacteremia in Hospitalized Children
por: Klieger, Sarah B., et al.
Publicado: (2014)

309 Clinical, Psycho-social and Cost Impacts of Performing Active Surveillance to Discontinue MRSA Contact Isolation for Patients Admitted to Medical-surgical Units
por: Power, Michelle, et al.
Publicado: (2014)

637 Control of Methicillin-Resistant Staphylococcus aureus (MRSA) in Long Term Care is Possible While Maintaining Patient Socialization without Isolation
por: Smith, Becky, et al.
Publicado: (2014)

316 Decolonization of Methicillin-Resistant Staphylococcus aureus (MRSA) Carriers in a Surgical Intensive Care Unit (SICU): Success Rate and Risk Factors for Decolonization Failure
por: Cho, Oh-Hyun, et al.
Publicado: (2014)

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

277 Molecular Epidemiology of Staphyloccocus aureus in Children with Bacteremia
por: Al-Zubeidi, Duha, et al.
Publicado: (2014)

726 Readmission rate associated with Staphylococcus aureus bacteremia
por: Lee, Jean, et al.
Publicado: (2014)

169 Rapid Testing using Verigene® Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-negative Bacteremia
por: Bork, Jacqueline T., et al.
Publicado: (2014)

893 Vancomycin Resistant Enterococcus (VRE) Rates in Ontario, Canada After the Discontinuation of VRE Screening and Control Practices by Some Hospitals: Interim Results
por: Lam, Freda, et al.
Publicado: (2014)

394 Influence of febrile neutropenia on the pharmacokinetics and dosage requirements of vancomycin
por: Shiotsuka, Shouichi, et al.
Publicado: (2014)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

734 Pneumococcal Bacteremia in Cancer Patients: A Case Series
por: Acevedo, Ileana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2l6vtud6qc4qcve0ucb1la142f